Latest news with #StratasysLtd
Business Wire
08-05-2025
- Business
- Business Wire
Stratasys Releases First Quarter 2025 Financial Results
MINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE)--Stratasys Ltd. (Nasdaq: SSYS), a leader in polymer 3D printing solutions, today announced its financial results for the first quarter ended March 31, 2025. Dr. Yoav Zeif, Stratasys' Chief Executive Officer, stated, 'We delivered another quarter of net profitability on an adjusted basis and positive cash from operating activities. It's particularly encouraging to see 7% sequential growth in our recurring revenue Consumables, demonstrating continued solid utilization of existing systems by our customers. Our ongoing strategic efforts to streamline the business are proving successful, and we are positioned to deliver improved profitability, while maintaining our ability to scale when capital spending recovers.' Dr. Zeif continued, 'With the recent close of the $120 million Fortissimo investment we further strengthened our balance sheet, which will support our ability to invest in profitable growth, both organically and through attractive opportunities. We continue to strengthen our position in additive manufacturing by expanding our portfolio of best-in-class technology, materials, and software. We believe we are well-positioned to drive increased cash flow and profitability from our streamlined operations and recurring stream of revenue as we move through the balance of the year.' Summary - First Quarter 2025 Financial Results Compared to First Quarter 2024: Revenue of $136.0 million compared to $144.1 million. GAAP gross margin of 44.3%, compared to 44.4%. Non-GAAP gross margin of 48.3%, compared to 48.6%. GAAP operating loss of $12.4 million, compared to an operating loss of $24.5 million. Non-GAAP operating income of $3.0 million, compared to an operating loss of $1.2 million. GAAP net loss of $13.1 million, or $0.18 per diluted share, compared to a net loss of $26.0 million, or $0.37 per diluted share. Non-GAAP net income of $2.9 million, or $0.04 per diluted share, compared to a net loss of $1.7 million, or $0.02 per diluted share. Adjusted EBITDA of $8.2 million, compared to $4.1 million. Cash provided by operating activities of $4.5 million, compared to $7.3 million. Financial Outlook: Based on current market conditions and assuming that the impacts of tariff policy, global inflationary pressures, relatively high interest rates and supply chain costs do not impede economic activity further, the Company is reiterating the following outlook for 2025: Full year revenue of $570 million to $585 million, improving sequentially over the course of the year. Based on current logistics and materials costs, full-year non-GAAP gross margins of 48.8%-49.2%, improving sequentially over the course of the year. Full year operating expenses in a range of $254 million to $257 million. Full year non-GAAP operating margins in a range of 4.0% to 5.0%. Adjusted EBITDA of $44 million to $50 million, or 7.8% to 8.5% of revenue. Capital expenditures of $25 million to $30 million. Expects to generate improved operating and free cashflow, at higher levels than in 2024. As a result of the Fortissimo investment, the Company's share count as of April 8 increased by approximately 11.65 million shares. The interest income the Company expects to generate from the $120 million investment will offset any potential dilution related to the share count. As a result, the Company is raising its 2025 annual earnings forecast as follows: GAAP net loss of $64 million to $49 million, up from $68 million to $53 million previously, and GAAP EPS of ($0.80) to ($0.61), an improvement as compared to ($0.93) to ($0.72) previously. Non-GAAP net income of $24 million to $30 million, up from $20 million to $26 million previously, and Non-GAAP EPS of $0.30 to $0.37, up from $0.28 to $0.35 previously. Appropriate reconciliations between our historical GAAP and non-GAAP financial measures, as well as between the GAAP and non-GAAP financial measures included in our updated financial outlook for 2025, are provided in the tables at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures. We have not included, however, a reconciliation of our guidance for non-GAAP gross margins to the most directly comparable GAAP financial measure, as we are unable to do so without unreasonable effort or with reasonable certainty from a quantitative perspective. Stratasys Ltd. First Quarter 2025 Webcast and Conference Call Details The Company plans to webcast its conference call to discuss its first quarter 2025 financial results on Thursday, May 8, 2025, at 8:30 a.m. (ET). The investor conference call will be available via live webcast on the Stratasys Web site at or directly at the following web address: To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at or by accessing the above-provided web address. Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products, healthcare, fashion and education. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world's leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care. To learn more about Stratasys, visit the Stratasys blog, Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the Company's websites, to share material, non-public information pursuant to the SEC's Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings. Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners. Cautionary Statement Regarding Forward-Looking Statements The statements in this press release regarding Stratasys' strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2025 and beyond, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the extent of our success at introducing new or improved products and solutions that gain market share; the extent of growth of the 3D printing market generally; the global macro-economic environment, including the extent of increased and/or reciprocal import tariffs that may be imposed by the U.S. and other countries, and the impact that will have on inflation, interest rates, economic activity and currency exchange rates on a global scale, and on the additive manufacturing industry, our company and our customers, in particular; changes in our overall strategy, including as related to any restructuring activities and our capital expenditures; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating and integrating into our existing business acquisitions or investments in new businesses, technologies, products or services; the potential adverse impact of recent global interruptions and delays involving freight carriers and other third parties on our supply chain and distribution network; global market, political and economic conditions, and in the countries in which we operate in particular; potential adverse effects of Israel's retaliatory war against the terrorist organization Hamas and, intermittently, its conflict with Iran and the Houthi terrorist group in Yemen; costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D 'Key Information - Risk Factors', Item 4, 'Information on the Company', Item 5, 'Operating and Financial Review and Prospects,' and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2024, which we filed with the U.S. Securities and Exchange Commission, or SEC, on March 6, 2025 (the ' 2024 Annual Report '). Readers are urged to carefully review and consider the various disclosures made throughout our 2024 Annual Report and the Reports of Foreign Private Issuer on Form 6-K that attach Stratasys' unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2025, which will be furnished to the SEC throughout 2025, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Use of Non-GAAP Financial Measures The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, and legal provisions, (ii) excluding non-cash items such as share-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items, (iii) for certain non-GAAP measures, after eliminating the impact of changes attributable to currency exchange rate fluctuations, and (iv) after excluding changes in revenues solely attributable to divestitures of former subsidiary companies. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in the tables below. Stratasys Ltd. Consolidated Balance Sheets (U.S. $ in thousands, except share data) (Unaudited) March 31, 2025 ASSETS Current assets Cash and cash equivalents $ 70,061 $ 70,200 Short-term bank deposits 80,000 80,500 Accounts receivable, net of allowance for credit losses of $3,048 and $3,058 as of March 31, 2025 and December 31, 2024, respectively 156,150 152,979 Inventories 169,881 179,809 Prepaid expenses 10,616 7,630 Other current assets 20,923 21,843 Total current assets 507,631 512,961 Non-current assets Property, plant and equipment, net 186,866 184,379 Goodwill 99,463 99,082 Other intangible assets, net 101,619 106,253 Operating lease right-of-use assets 31,097 32,169 Long-term investments 81,518 80,205 Other non-current assets 14,950 14,697 Total non-current assets 515,513 516,785 Total assets $ 1,023,144 $ 1,029,746 LIABILITIES AND EQUITY Current liabilities Accounts payable $ 38,032 $ 44,977 Accrued expenses and other current liabilities 36,310 39,749 Accrued compensation and related benefits 34,905 29,206 Deferred revenues - short-term 51,897 46,347 Operating lease liabilities - short-term 6,921 6,935 Total current liabilities 168,065 167,214 Non-current liabilities Deferred revenues - long-term 20,138 19,057 Deferred income taxes 459 507 Operating lease liabilities - long-term 24,363 25,155 Contingent consideration - long-term 5,089 4,933 Other non-current liabilities 20,189 19,889 Total non-current liabilities 70,238 69,541 Total liabilities $ 238,303 $ 236,755 Contingencies (see note 12) Equity Ordinary shares, NIS 0.01 nominal value, authorized 180,000 shares; 72,657 shares and 71,982 shares issued at March 31, 2025 and December 31, 2024, respectively; 72,391 shares and 71,716 shares outstanding at March 31, 2025 and December 31, 2024, respectively $ 203 $ 202 Treasury shares at cost, 266 shares at March 31, 2025 and December 31, 2024 (1,995 ) (1,995 ) Additional paid-in capital 3,129,236 3,123,024 Accumulated other comprehensive loss (9,340 ) (8,031 ) Accumulated deficit (2,333,263 ) (2,320,209 ) Total equity 784,841 792,991 Total liabilities and equity $ 1,023,144 $ 1,029,746 Expand Stratasys Ltd. Consolidated Statements of Operations (U.S. $ in thousands, except share data) Three Months Ended March 31, (Unaudited) 2025 2024 Revenues Products $ 93,795 $ 99,196 Services 42,251 44,854 136,046 144,050 Cost of revenues Products 47,268 49,757 Services 28,539 30,396 75,807 80,153 Gross profit 60,239 63,897 Operating expenses Research and development, net 18,792 23,977 Selling, general and administrative 53,851 64,373 72,643 88,350 Operating loss (12,404 ) (24,453 ) Financial income, net 1,473 1,217 Loss before income taxes (10,931 ) (23,236 ) Income tax expense 455 716 Share in losses of associated companies 1,668 2,031 Net loss $ (13,054 ) $ (25,983 ) Net loss per ordinary share- basic and diluted $ (0.18 ) $ (0.37 ) Weighted average ordinary shares outstanding- basic and diluted 71,967 69,993 Expand Stratasys Ltd. Reconciliation of GAAP net loss to Adjusted EBITDA Three months ended March 31, 2025 2024 (U.S. $ in thousands) Net loss $ (13,054 ) $ (25,983 ) Financial income, net (1,473 ) (1,217 ) Income tax expenses 455 716 Share in losses of associated companies 1,668 2,031 Depreciation expenses 5,124 5,305 Amortization expenses 5,428 7,543 Non-cash stock-based compensation expense 6,213 8,649 Revaluation of investment - 1,900 Contingent consideration 645 511 Legal and other expenses 1,818 3,628 Restructuring and other related costs 1,346 1,023 Adjusted EBITDA $ 8,170 $ 4,106 Expand Stratasys Ltd. Reconciliation of GAAP Net Loss to Non-GAAP Net Income Forward Looking Guidance: Fiscal Year 2025 (U.S. $ in millions, except share data) Low High GAAP net loss $(64) to $(49) Adjustments Stock-based compensation expense $25 to $27 Intangible assets amortization expense $22 to $24 Reorganization and other $30 to $34 Tax expense related to Non-GAAP adjustments $2 to $3 Non-GAAP net income $24 to $30 GAAP loss per share $(0.80) to $(0.61) Non-GAAP diluted earnings per share $0.30 to $0.37 Reconciliation of GAAP Net Loss to Adjusted EBITDA Forward Looking Guidance: Fiscal Year 2025 (U.S. $ in millions, except share data) Low High GAAP net loss $(64) to $(49) Adjustments Stock-based compensation expense $25 to $27 Intangible assets amortization expense $22 to $24 Reorganization and other $30 to $34 Tax expense related to Non-GAAP adjustments $2 to $3 Other non-operating expense $- to $- Depreciation $20 to $20 Adjusted EBITDA $44 to $50 Expand
Yahoo
03-04-2025
- Business
- Yahoo
Stratasys to Showcase its Leading Additive Manufacturing Ecosystem and Unveil New Solutions at RAPID + TCT 2025
Company to highlight critical applications and use cases, and lead discussions on how customers are using additive manufacturing to transform design, tooling and production EDEN PRAIRIE, Minn. & REHOVOT, Israel, April 03, 2025--(BUSINESS WIRE)--Stratasys Ltd. (NASDAQ: SSYS) today announced its product and speaker lineup for RAPID + TCT 2025, North America's largest additive manufacturing and industrial 3D printing event, taking place April 8–10 in Detroit, Michigan. The company will unveil multiple new solutions and materials, host live product demonstrations, and present in a dozen conference sessions—all focused on helping manufacturers transform their operations across the manufacturing lifecycle. Visitors to booth #2501 will experience Stratasys' full additive ecosystem in action, featuring six 3D printers across five technologies, over 120 printed parts, and a range of software, materials, and post-processing solutions. "Additive Manufacturing stands at an important crossroads as manufacturers across the globe decide on the right path forward during a period of opportunity, risk and uncertainty," said Rich Garrity, Chief Business Unit Officer, Stratasys. "The need for AM has never been greater and the team looks forward to discussing in Detroit the clear advantages of integrating additive into the manufacturing floor to lower costs, increase efficiency and overcome challenges such as supply chain stability." Stratasys will unveil its new Neo800+™ stereolithography printer and PolyJet ToughONE™ material live on the show floor, reinforcing the company's commitment to developing solutions that deliver production-grade performance, repeatability, and efficiency. The show will also feature a dedicated PolyJet ToughONE functionality station, including drill and pull testing, and an air hockey table demonstration using printed components—highlighting the strength of the material and just several of the applications that could be developed within a single system. In addition, Stratasys will spotlight CALLUM SKYE, a low-volume, luxury EV developed using Stratasys technologies, demonstrating how additive manufacturing can scale from concept design through end-use production. Stratasys will also introduce several new products and materials across its FDM® and P3™ DLP platforms at RAPID + TCT, expanding its additive capabilities for high-demand applications in aerospace, electronics, industrial manufacturing, and healthcare. New FDM announcements include: VICTREX AM™ 200, a high-performance PEEK-based material offering excellent mechanical strength, heat resistance, and chemical durability for applications such as aerospace brackets and industrial tooling. PC-ESD, a polycarbonate blend with electrostatic discharge (ESD) properties, designed for static-sensitive applications in electronics assembly and production environments. New P3 DLP announcements include: GrabCAD® Print Pro for Origin, rounding out Print Pro's availability across all Stratasys technologies, enabling streamlined print preparation and enhanced workflow control for Origin users. A new ESD photopolymer, Loctite 3D IND3380™ ESD , delivering electro static-discharge-safe properties for parts used in automotive tooling, industrial machinery, and aerospace components. Throughout the event, Stratasys leaders and customers will take the stage to share how additive is being used to solve real-world challenges. Key sessions include (all times Eastern Daylight Time): Tuesday, April 8 8:30-10:00 a.m.: Yoav Zeif, "AM Impact: View from the C-suite Panel," SME Mainstage 10:30-11 a.m.: Anirudh Krishnakumar, "Maximizing 3D Performance: Leveraging IoT and OEE for AM Success," TechHub Stage, #3720 11-11:30 a.m.: Fadi Abro, "Accelerating Innovation for Customers: F3300 and Its Impact to Ford's AM Capabilities," Room 430A 11-11:30 a.m.: Neil Hopkinson, "Mindful Manufacturing™ in Action: How SAF Re-life Turns AM Waste into Profitable Parts," Room 413B 11-11:30 a.m.: Conrad Smith, "Innovation to Industrialization – Approaches Throughout the Manufacturing Process", AeroDef Room 1-2 p.m.: Yoav Zeif, "Afternoon CEO Keynote: State of the AM Industry and Customer Panel on Real-world Applications," SME Mainstage Wednesday, April 9 11-11:30 a.m.: Jesse Roitenberg, "AM and Workforce Development: Stratasys and SME Impact on the Next Generation," Room 413A 2:30-3 p.m.: Guy Shirazi, "Stratasys PolyJet: Like You've Never Met Before," Tech Hub Stage, #3720 2:30-3 p.m.: Andrew Graves, "Neo SLA Models for Advanced Aerospace Wind Tunnel Testing," Room 410A 2:30-3 p.m.: Adam Donfrancesco, CALLUM, "Revolutionizing Low-volume Production: AM in the Development of the CALLUM SKYE" Room 430A Thursday, April 10 10:30-11 a.m.: Victor Gerdes, "Secure Scaling of AM: Mitigating Cyber Risks in 3D Printing," Room 411C 11-11:30 a.m.: Eric Yeung, "Fire the 'Laser' by Austin Powers. SLA Productivity Enhancement Beyond the Laser", Room 413A Noon-12:45 p.m.: Angelo Tardugno, "3MF: The 3MF File Format for 3D Printing: Applications, Extensions and Integrations", SME Theater Stratasys' full presence at RAPID + TCT includes hands-on product demos, technical talks, and curated tours for students and professionals. To schedule a meeting with the team or view the full event agenda, visit About Stratasys Stratasys is a global leader in additive manufacturing, transforming how things are made with innovative 3D printing solutions for industries including aerospace, automotive, healthcare, consumer products, and industrial manufacturing. Through its connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys delivers competitive advantages at every stage of the product lifecycle. The world's leading organizations trust Stratasys to streamline production, accelerate innovation, and improve efficiency. For more information, visit follow Stratasys on LinkedIn, Facebook, and X, or visit the Stratasys blog. Stratasys reserves the right to share material non-public information using its website and social media channels, as per SEC Regulation FD. View source version on Contacts Media ContactsErik SniderStratasys+1 Chris ReeseStratasys+1 Investor Relations Contact Yonah LloydStratasys+972 74 745
Associated Press
02-04-2025
- Business
- Associated Press
Stratasys Expands PolyJet into Functional Prototyping and Selected End-use Parts for a Variety of Applications with the Introduction of PolyJet ToughONE™
EDEN PRAIRIE, Minn. & REHOVOT, Israel--(BUSINESS WIRE)--Apr 2, 2025-- Stratasys Ltd. (NASDAQ: SSYS) today introduced PolyJet ToughONE™ White, an advanced material engineered for tough and durable functional prototyping and end-use parts on its high-end platforms—delivered with the signature ease of use, full-color realism, and multi-material versatility customers have come to expect. This press release features multimedia. View the full release here: EV charger and pipe produced with PolyJet ToughONE™ With the launch of this new material, Stratasys' PolyJet printing becomes the premiere 3D printing solution that combines exceptional design precision with functional strength. Engineers and designers no longer have to choose between visual accuracy and function as they can create prototypes and end-use parts without compromising aesthetics or durability. PolyJet ToughONE material features enhanced impact resistance and flexibility that allow for drillable, millable, and self-tapping features. This new material is an ideal choice for producing functional prototypes across all market segments. It is well-suited for creating accurate manufacturing aids, jigs, and fixtures, with the option for color labeling. Additionally, it is perfect for custom housings, brackets, and covers in consumer electronics, impact-resistant components, and robotic end-effectors for industrial applications. PolyJet ToughONE material also finds applications in many other key sectors such as automotive, consumer goods, and eyewear. 'Manufacturers are constantly balancing speed, cost, and performance when developing new products, and every unnecessary prototype iteration adds delays and expense,' said Rich Garrity, Chief Business Unit Officer at Stratasys. 'With ToughONE, we're giving engineers a material that lets them move from concept to functional testing faster, with precision and performance built in.' PolyJet ToughONE material also produces complex part geometries, including thin walls, snap fits, and living hinges, while maintaining high dimensional accuracy and surface quality. It integrates seamlessly with other PolyJet materials, allowing for hybrid models that combine different mechanical properties or different colors within a single part. Stratasys will debut its PolyJet ToughONE material and printed parts at RAPID 2025 in Detroit on April 9, showcasing how it streamlines workflows and boosts manufacturing efficiency across multiple industries. For more information, visit About Stratasys Stratasys is a global leader in additive manufacturing, transforming how things are made with innovative 3D printing solutions for industries including aerospace, automotive, healthcare, consumer products, and education. Through its connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys delivers competitive advantages at every stage of the product lifecycle. The world's leading organizations trust Stratasys to transform product design, streamline manufacturing, and improve patient care. For more information, visit follow Stratasys on LinkedIn, Facebook, and X, or visit the Stratasys blog. Stratasys reserves the right to share material non-public information using its website and social media channels, as per SEC Regulation FD. Stratasys, PolyJet ToughONE, PolyJet and ToughONE are trademarks or registered trademarks of Stratasys Ltd. and/or its affiliates. All other trademarks are the property of their respective owners. Note Regarding Forward-Looking Statement The statements in this press release relating to Stratasys' beliefs regarding the benefits consumers will experience from using the PolyJet ToughONE™, its time of general ability and other statements in this press release are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower-margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; to the extent of our success at successfully consummating acquisitions or investments in new businesses, technologies, products or services; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and other risk factors set forth under the caption 'Risk Factors' in Stratasys' most recent Annual Report on Form 20-F, filed with the Securities and Exchange Commission (SEC) on March 11th, 2024. Readers are urged to carefully review and consider the various disclosures made throughout our 2023 Annual Report and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are made as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Stratasys Corporate, Israel & EMEA Erik Snider [email protected] +972 74 745 6053 Stratasys Corporate, North America & EMEA Chris Reese [email protected] +1 651 357 0877 Investor Relations Contact Yonah Lloyd [email protected] +972 74 745 4919 SOURCE: Stratasys Ltd. Copyright Business Wire 2025.
Globe and Mail
07-03-2025
- Business
- Globe and Mail
3D Printing Medical Devices Market worth $6.9 billion
"Major players in 3D printing medical devices market include Stratasys Ltd. (Israel), EnvisionTEC (US), 3D Systems, Inc. (US), EOS (US), Renishaw plc (UK), Materialise (Belgium), 3T Additive Manufacturing Ltd. (US), GENERAL ELECTRIC COMPANY (US)" North America accounted for the largest share of 45.5% of the total 3D printing medical devices market in 2023. This market is projected to reach USD 2,720.6 million by 2028 from USD 1,244.0 million in 2023, at a CAGR of 16.9% during the forecast period. 3D Printing Medical Devices Market in terms of revenue was estimated to be worth $2.7 billion in 2022 and is poised to reach $6.9 billion by 2028, growing at a CAGR of 17.1% from 2022 to 2028 according to a new report by MarketsandMarkets™. 3D printing enables rapid prototyping and iteration of designs, reducing the time and cost required for traditional manufacturing processes. This advantage has been embraced by product designers, engineers, and architects, facilitating faster innovation and time-to-market for new products. Continuous technological advancements in 3D printing have significantly improved the quality, speed, and efficiency of the devices. Innovations in materials, printing processes, and software have expanded the industry. Various industries, including aerospace, automotive, healthcare, consumer goods, and education, have increasingly adopted 3D printing for various applications. As more organizations recognize the benefits and potential of 3D printing, the demand for 3D printing devices continues to grow. e range of applications and made 3D printing more accessible to various industries. Download an Illustrative overview: Software and Services component segment to register a significant growth rate over the forecast period of 2023-2028 Based on the component segment, Software, and services are projected to reach USD 3.2 billion in 2028 from USD 1.5 billion in 2023 with a CAGR of 17.0%. The services segment in 3D printing medical devices includes services such as design assistance, pre-processing, post-processing, and quality control. Software solutions are increasingly being utilized to streamline and automate these workflows. Software platforms are used to manage the entire additive manufacturing process, from design to final production, ensuring accuracy, consistency, and traceability. 3D printing allows for highly customized and personalized medical devices. The software segment plays a crucial role in enabling this customization by providing software solutions that can generate patient-specific designs based on medical imaging data. These software tools help in converting imaging data into 3D models that can be used for creating personalized implants, prosthetics, and surgical guides. Based on Application, Custom Prosthetics and Implants are anticipated to witness the highest growth during the forecast period. Compared to conventional manufacturing techniques, 3D printing offers faster production times for custom prosthetics and implants. This can be particularly advantageous for patients who require timely solutions, such as in urgent medical cases or situations where a quick turnaround is crucial. The increasing use of custom prosthetics and implants demonstrates the potential of 3D printing and personalized medicine in improving patient care. It allows for patient-specific solutions, faster production, cost-effectiveness, and iterative design processes, ultimately enhancing patient outcomes in the field of medical devices. Based on Technology, Laser Beam Melting is witnessed to have the Highest growth during the forecast period. Laser Beam melting is witnessed to grow with the highest CAGR of 18.0% during the forecast period this is due to the following factors- Laser beam melting allows for the production of highly customized and patient-specific medical devices. It enables the creation of complex geometries and intricate designs, which is particularly important for personalized implants, prosthetics, and surgical instruments. Each device can be tailored to the specific requirements of an individual patient, resulting in better fit, comfort, and functionality. Laser beam melting technology offers high levels of accuracy and precision in the production of medical devices. The focused laser beam allows for precise control of melting and solidification, resulting in parts with tight tolerances and fine details. This level of precision is crucial for medical devices where accuracy and proper fit are of utmost importance. On the Basis of End Users, Hospitals & Surgical centers are anticipated to have the highest growth during the forecast period. In 2023, the hospitals & surgical centers segment accounted for 33.9% of the 3D printing medical devices market. This segment is projected to reach USD 2,372.2 million by 2028 from USD 1,073.1 million in 2023, at a CAGR of 17.2% during the forecast period. The large share of this end-user segment can be attributed to the increasing number of 3D printing laboratories, expansion of existing 3D printing laboratories, the outsourcing of certain manufacturing functions to 3D printing vendors, and the increasing demand for customized/fabricated solutions. North America to dominate the 3D Printing medical devices market. North America's 3D printing medical devices market is anticipated to register the highest growth over the forecast period of 2023 to 2028. North America accounted for the largest share of 45.5% of the total 3D printing medical devices market in 2023. This market is projected to reach USD 2,720.6 million by 2028 from USD 1,244.0 million in 2023, at a CAGR of 16.9% during the forecast period. market. The large share of North America can be attributed because North America has a well-developed and advanced healthcare infrastructure, including hospitals, clinics, and research institutions. This infrastructure provides a conducive environment for the adoption of innovative technologies like 3D printing in the medical field. The availability of skilled healthcare professionals, researchers, and industry experts contributes to the growth of the 3D printing medical devices market. Asia Pacific is witnessed to grow with the highest CAGR of 18.5% during the forecast period. There is an increasing awareness and acceptance of 3D printing in the healthcare industry across the Asia Pacific region. Industry conferences, trade shows, and educational programs are promoting the benefits and applications of 3D printing in medical devices. This growing awareness is driving the adoption of 3D printing technology among healthcare providers, driving market growth. The Asia Pacific region has been witnessing significant growth and development in its healthcare infrastructure. Countries like China, Japan, South Korea, and Singapore have been investing heavily in healthcare facilities, hospitals, and research institutions. This expanding healthcare infrastructure provides a favorable environment for the adoption of advanced technologies like 3D printing in medical applications. 3D Printing Medical Devices Market Dynamics: Drivers: Easy development of customized medical products using 3D printing Restraints: Stringent regulatory process for the approval of 3D-printed medical devices Opportunities: Increasing adoption of CAD/CAM technology and desktop printers Challenges: Socio-ethical concerns related to the use of 3D-printed products Key Market Players: Major players in 3D printing medical devices market include Stratasys Ltd. (Israel), EnvisionTEC (US), 3D Systems, Inc. (US), EOS (US), Renishaw plc (UK), Materialise (Belgium), 3T Additive Manufacturing Ltd. (US), GENERAL ELECTRIC COMPANY (US), Carbon, Inc. (US), Prodways Group (France), SLM Solutions (Germany), Organovo Holdings Inc. (US), Groupe Gorgé (France), Cyfuse Biomedical K.K. (Tokyo), FIT AG (Germany), and Wacker Chemie AG (Germany) among others. Get 10% Free Customization on this Report:
